Search
for
Sort by
Research 571–600 of 1000+
- Aldesleukin
- PREVALENCE OF SKIN DISEASES IN A DERMATOLOGY OUTPATIENT CLINIC IN RIMS, KADAPA, A CROSS - SECTIONAL, RETROSPECTIVE STUDY
- Subject Index
- Les hormones sexuelles et la peau : questionnaire à l'attention des vétérinaires praticiens. Mise à jour bibliographique et synthèse
- Cutaneous Lupus Erythematosus
- Lichen planopilaris
- Contents
- Non-Neoplastic Disorders of Hair
- Alopecia
- Topische Immuntherapie mit Diphenylcyclopropenon bei verschiedenen Typen der Alpecia areata: Assoziation zu klinischen Parametern und einem funktionellen Genpolymorphismus des Interleukin-6-Promotors
- Alopecia and its medical management
- Book Reviews
- ANNOUNCEMENTS
- 미녹시딜 도포후 전신에 발생한 다모증 1 례
- Cutaneous manifestations of systemic infection in children
- Dermatologic therapy: December 1987 to December 1988
- The role of integrin alphavbeta6 in impaired wound healing and hair follicle regeneration
- Mechanistic synergy of hair growth promotion by the Avicennia marina extract and its active constituent (avicequinone C) in dermal papilla cells isolated from androgenic alopecia patients
- Alopecia areata
- Epithelial elements in superficial angiomyxomas: mimicry of adnexal development, and mesenchymal‐to‐epithelial transition
- Alopecia areata: a new treatment plan
- Therapy and Antifungal Susceptibility Profile of Microsporum canis
- Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia
- Alopecia Areata in a Dog: Clinical, Dermoscopic and Histological Features
- Sweat Hypersensitivity‐Induced Urticaria and Sebaceous Adenitis in an American Saddlebred
- Androgenic alopecia and dutasteride in hair mesotherapy: A short review
- Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications
- Evaluation of Therapeutic Potential of a Selective 5α-reductase Inhibitor against Glioblastoma: Molecular Docking and In Vitro Insights
- M2 Macrophage and Extracellular Matrix Genes Are Enriched in High‐Activity Lichen Planopilaris
- Bacillus Calmette-Guerin (BCG) Site Reaction After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination